Alnylam Pharmaceuticals
ALNY
ALNY
290 hedge funds and large institutions have $9.06B invested in Alnylam Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 110 increasing their positions, 88 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
25% more repeat investments, than reductions
Existing positions increased: 110 | Existing positions reduced: 88
2% more funds holding
Funds holding: 283 → 290 (+7)
0.41% less ownership
Funds ownership: 91.58% → 91.17% (-0.41%)
Holders
290
Holding in Top 10
12
Calls
$82.4M
Puts
$52.5M
Top Buyers
| 1 | +$87.6M | |
| 2 | +$73.9M | |
| 3 | +$71.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$41.1M |
| 5 |
MC
Maverick Capital
Dallas,
Texas
|
+$38M |
Top Sellers
| 1 | -$43.7M | |
| 2 | -$24.2M | |
| 3 | -$18.5M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$18M |
| 5 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$17.2M |